by Kelcie Moseley-Morris | Jul 1, 2026 | Abortion, abortion bans, Abortion Pills, Abortion Restrictions, Gender-Affirming Care, Hawaii, health care, Iowa, medication abortion, mifepristone, misoprostol, Mississippi, News, Reproductive Rights, Shield Law, Shield Laws, Tennessee, Vaccines
Several laws restricting access to medications that can be used to terminate a pregnancy and others placing limits on minors’ access to sexual and reproductive healthcare — including the HPV vaccine — take effect today in Iowa, Mississippi and Tennessee. Many bills were considered in state legislatures earlier this year that would have added legal restrictions to mifepristone and misoprostol…
Source
by Chris Walker | Jun 8, 2026 | Abortion, abortion medication, Food and Drug Administration, mifepristone, News, Supreme Court
The U.S. Food and Drug Administration (FDA) has launched a study that purports to examine the safety of the widely used abortion medication mifepristone, a move that critics say could be used as a means to further regulate the drug and restrict abortion access. FDA administrators deny that the study, revealed in a Wall Street Journal report late last week, is new, asserting it has been going…
Source
by Emma Cieslik | May 19, 2026 | Abortion, Comstock Act, Dobbs v. Jackson, mifepristone, News Analysis, Roe v. Wade, Supreme Court
On May 1, the New Orleans-based 5th U.S. Circuit Court of Appeals blocked the mailing of mifepristone, a common abortion medication. The ruling restricted distribution and use of the medication to in-person clinic visits only, even as the number of brick-and-mortar abortion clinics has continued to shutter over the past year, and some red states blocked access to mail order pills.
Source
by Grace E. Howard | May 5, 2026 | Abortion, Abortion Pills, Alabama, Criminalization, Dobbs v. Jackson Women’s Health Organization, mifepristone, Op-Ed, Telehealth
In the aftermath of the Dobbs v. Jackson Women’s Health Organization Supreme Court decision that overturned Roe v. Wade, there has been increased movement toward criminalization of abortion. The Fifth Circuit Court recently ordered the Food and Drug Administration (FDA) to rescind guidance permitting the use of telemedicine for mifepristone, one of the two medications used for medication…
Source
by Kelcie Moseley-Morris | May 4, 2026 | abortion bans, Abortion Pills, FDA, mifepristone, News, Samuel Alito, Telehealth
The U.S. Supreme Court issued a temporary stay on an appeals court ruling from Friday that was blocking remote access to an abortion drug, restoring access until at least May 11. The administrative stay, issued by Justice Samuel Alito, pauses Friday’s decision by the 5th Circuit Court of Appeals. That ruling blocked a 2023 rule adopted by the U.S. Food and Drug Administration allowing…
Source
by Jessica Corbett | May 2, 2026 | Abortion, Abortion Access, Appeals Court, Louisiana, mifepristone, News, Reproductive Rights, Roe v. Wade, Telehealth
Rights advocates swiftly sounded the alarm on Friday after the infamously far-right U.S. Court of Appeals for the 5th Circuit temporarily blocked a federal rule allowing mifepristone to be dispensed by mail, dramatically curtailing access to the medication — commonly used for abortion and early miscarriage care — nationwide, particularly in states with policies hostile to reproductive freedom.
Source